Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript

ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript

Acorda Therapeutics Inc.
Start Time: 16:30 End Time: 17:02 Acorda Therapeutics, Inc. (ACOR) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 PM ET Company Participants Ron Cohen - Founder, President and CEO Mike Gesser - CFO Tierney Saccavino - EVP, Corporate Communications Conference Call Participants Muzamil Saleem - H.C. Wainwright Presentation Operator Good afternoon. Welcome to Acorda Therapeutics First Quarter 2022 Financial and Business Update. Please be advised that this call is being recorded at the company's request. I will now introduce you to our host, Tierney Saccavino, Acorda's Communications Consultant. Tierney, please go ahead. Tierney Saccavino Thank you, Bethany, and good afternoon, everyone. Before we begin, let me remind everyone that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public, and we encourage you to refer to those filings. Today, during Q&A, we will first take calls from our analysts and then

For further details see:

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Acorda Therapeutics Inc.
Stock Symbol: ACOR
Market: NASDAQ
Website: acorda.com
Menu
ACOR ACOR Quote ACOR Short ACOR News ACOR Articles ACOR Message Board
Get ACOR Alerts

News, Short Squeeze, Breakout and More Instantly...